Josune Egea

405 citations
11 papers · 237 indexed · h-index 7
Topics
Immunotherapy and Immune Responses (7 papers)CAR-T cell therapy research (4 papers)Immune Cell Function and Interaction (4 papers)

In The Last Decade

Josune Egea

11 papers receiving 231 citations

Peers

Josune Egea
Comparison fields: 5 of 48
  • Oncology 112
  • Immunology 108
  • Molecular Biology 101
  • Hepatology 30
  • Pulmonary and Respiratory Medicine 23
Replace Adam Kornberg with:
Adam Kornberg United States
Conrad Rauber Germany
Natalie J. Neubert Switzerland
Akshaya Ramachandran United States
Ping‐Yi Wu Taiwan
Matthew Blackburn United States
Jiankun Liang China
Jordi Abril‐Fornaguera Spain
Chongsheng Qian China
Kohsuke Okita Japan
Josune Egea relative to Adam Kornberg United States Adam Kornberg's profile →
Citations per field
00.5×3.9×
Adam Kornberg · 1×
Citations per year

Countries citing papers authored by Josune Egea

Since Specialization
Citations

This map shows the geographic impact of Josune Egea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josune Egea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josune Egea more than expected).

Fields of papers citing papers by Josune Egea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josune Egea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josune Egea. The network helps show where Josune Egea may publish in the future.

Co-authorship network of co-authors of Josune Egea

This figure shows the co-authorship network connecting the top 25 collaborators of Josune Egea. A scholar is included among the top collaborators of Josune Egea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josune Egea. Josune Egea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 32
2 1
3 22
4 5
5 1
6 13
7 8
8 23
9 116
10
[Impact of a quality program in hemodialysis].
11
11
[Nosocomial transmission of the hepatitis C virus in hemodialysis: monitors, personnel, or both?].
5

About Josune Egea

Josune Egea is a scholar working on Immunology, Oncology and Hepatology, having authored 11 papers that have together received 237 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Immunology (108 citations), Oncology (112 citations) and Hepatology (30 citations). Josune Egea has collaborated with scholars based in Spain, United States and Argentina. Frequent co-authors include Marta Ruiz, Juan José Lasarte, Pablo Sarobe, Leyre Silva, Diana Llópiz, Lorea Villanueva, Bruno Sangro, Tamara Iglesias, B. Vasseur and Ignacio Melero. Their work appears in journals such as Cancer Research, Frontiers in Immunology and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026